TL;DR: Actipulse Neuroscience is a Y Combinator Winter 2022 startup Bringing non-invasive brain stimulation from the hospital to the home, currently active with a team of 38.
Bringing non-invasive brain stimulation from the hospital to the home
Last verified:
Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment. Currently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases.
Built by LemStudio
Yes. Actipulse Neuroscience was funded by Y Combinator in the Winter 2022 batch. Bringing non-invasive brain stimulation from the hospital to the home
Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their…
Actipulse Neuroscience was part of Y Combinator's Winter 2022 batch.
Actipulse Neuroscience has a team of 38 people according to Y Combinator's directory.
Actipulse Neuroscience is currently listed as Active with a team of 38 in Y Combinator's directory.
Loading interactive view…